darlifarnib
·Code: darlifarnib
darlifarnib: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Kura Oncology, Inc. (KURA) | Phase 1 |
Clinical Trials (1)
Phase 1, First-in-Human, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of KO-2806 When Administered as Monotherapy and in Combination Therapy in Adult Patients With Advanced Solid Tumors
Frequently asked questions
Who is developing darlifarnib?
darlifarnib is being developed by Kura Oncology, Inc..
How many clinical trials involve darlifarnib?
BioSniper tracks 1 clinical trial involving darlifarnib.
Get deeper analysis on darlifarnib
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis